%0 Journal Article
%T Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass
%A Faiza Al Aisary
%A Fatma Ramadhan
%A Khalsa Al Hatali
%A Khawla Al Musalhi
%A Manal Al Kindi
%A Thuraya Al Rawahi
%A Waad-Allah Mula-Abed
%J Archive of "Oman Medical Journal".
%D 2016
%R 10.5001/omj.2016.68
%X To evaluate the validity and compare the performance of cancer antigen-125 (CA-125), human epididymis protein 4 (HE4), the risk of malignancy index (RMI), and the risk of ovarian malignancy algorithm (ROMA) in the diagnosis of ovarian cancer in patients with ovarian lesions discovered during their preoperative work-up investigations
%K CA-125 Antigen
%K Human Epididymis-specific Protein E4
%K Risk of Malignancy Index (RMI)
%K Risk of Ovarian Malignancy Algorithm (ROMA)
%K Ovarian Neoplasms.
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996955/